Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 08 Mar 2023
3-year results show that patients who underwent low-risk aortic valve replacement continue to report lower rates of all-cause mortality and stroke with TAVI compared to surgery
Read Full NewsHere's some of what is coming soon to NeurologyLive® this week.
Continuem's PIPE-307 trial for relapsing-remitting multiple sclerosis failed to meet primary goals, yet the company remains committed to exploring future therapies.
Gain Therapeutics advances Parkinson's treatment with GT 2287, showcasing promising safety and tolerability in ongoing trials. Discover the latest findings.
Daily Lemon Water Lowers Serum Urate Levels in Patients With Hyperuricemia
COPD in 2025: Year in Review
FDA Approves FUROSCIX On-Body Injector for Pediatric Patients, Accepts sNDA for ReadyFlow Autoinjector
Nephrology in 2025: Year in Review
1.
Which women need more than mammograms for breast cancer screening?
2.
Implant-based reconstruction linked to increased risk of breast lymphomas
3.
Prostate cancer screening seems to be improved by PSA, biomarker testing, and MRI combined.
4.
New CAR T-Cell Therapy Approved for Leukemia
5.
Alarm Over Pharma-China Link; Taking Screening to the People; Agriculture and Cancer
1.
What You Need To Know About Secondary Polycythemia: Treatment & Symptoms
2.
What is Red Cell Distribution Width and Why Should You Care?
3.
Uncovering the Mysteries of Breast Cancer: The Journey to a Cure
4.
Revolutionizing Oncology: AI in Radiology, Machine Learning in Pathology, and Deep Learning for Cancer Detection
5.
Unlocking the Secret to Accurate ANC Calculation with This Informative Blog Post
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
Understanding the causes of anemia in adults beyond nutritional deficiencies
4.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
5.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge